0 453

Cited 14 times in

Cited 10 times in

Objectively measured far vision impairment and sarcopenia among adults aged >= 65 years from six low- and middle-income countries

DC Field Value Language
dc.contributor.authorSmith, Lee-
dc.contributor.authorLopez-Sanchez, Guillermo F.-
dc.contributor.authorJacob, Louis-
dc.contributor.authorBarnett, Yvonne-
dc.contributor.authorPardhan, Shahina-
dc.contributor.authorVeronese, Nicola-
dc.contributor.authorSoysal, Pinar-
dc.contributor.authorTully, Mark A.-
dc.contributor.authorGorely, Trish-
dc.contributor.authorIl Shin, Jae-
dc.contributor.authorKoyanagi, Ai-
dc.date.accessioned2022-02-23T00:59:02Z-
dc.date.available2022-02-23T00:59:02Z-
dc.date.created2021-07-06-
dc.date.issued2021-11-
dc.identifier.issn1594-0667-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/187477-
dc.description.abstractBackground There are currently no studies on visual impairment and sarcopenia. We investigated the cross-sectional association between objectively measured far vision impairment and sarcopenia in a nationally representative sample of older adults aged 65 years and over from six low- and middle-income countries (LMICs). Methods Cross-sectional, community-based data from the study on global ageing and adult health (SAGE) were analyzed. Far vision acuity was measured using the tumbling E LogMAR chart and classified as: no vision impairment (6/12 or better); mild vision impairment (6/18 or better but worse than 6/12); moderate vision impairment (6/60 or better but worse than 6/18); severe vision impairment (worse than 6/60). Sarcopenia was defined as having low skeletal muscle mass and either a slow gait speed or a weak handgrip strength. Associations were assessed with multivariable logistic regression. Results Fourteen thousand five hundred and eighty five individuals aged >= 65 years were included in the analysis [mean (SD) age 72.6 (11.5) years; 54.1% females]. After adjustment for multiple potential confounders, compared to those with no vision impairment, the OR (95% CI) for sarcopenia in those with mild, moderate, and severe vision impairment were 1.10 (0.87-1.40), 1.69 (1.25-2.27), and 3.38 (1.69-6.77), respectively. The estimates for females and males were similar. Conclusions The odds for sarcopenia increased with increasing severity of far vision impairment among older people in LMICs. The mere co-occurrence of these conditions is concerning, and it may be prudent to implement interventions to address/prevent sarcopenia in those with far vision impairment through the promotion of physical activity and appropriate nutrition.-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherEditrice Kurtis-
dc.relation.isPartOfAGING CLINICAL AND EXPERIMENTAL RESEARCH-
dc.relation.isPartOfAGING CLINICAL AND EXPERIMENTAL RESEARCH-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleObjectively measured far vision impairment and sarcopenia among adults aged >= 65 years from six low- and middle-income countries-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Pediatrics (소아과학교실)-
dc.contributor.googleauthorSmith, Lee-
dc.contributor.googleauthorLopez-Sanchez, Guillermo F.-
dc.contributor.googleauthorJacob, Louis-
dc.contributor.googleauthorBarnett, Yvonne-
dc.contributor.googleauthorPardhan, Shahina-
dc.contributor.googleauthorVeronese, Nicola-
dc.contributor.googleauthorSoysal, Pinar-
dc.contributor.googleauthorTully, Mark A.-
dc.contributor.googleauthorGorely, Trish-
dc.contributor.googleauthorIl Shin, Jae-
dc.contributor.googleauthorKoyanagi, Ai-
dc.identifier.doi10.1007/s40520-021-01841-y-
dc.relation.journalcodeJ03502-
dc.identifier.eissn1720-8319-
dc.subject.keywordSarcopenia-
dc.subject.keywordVisual impairment-
dc.subject.keywordLow-
dc.subject.keywordand middle-income countries-
dc.subject.keywordOlder adults-
dc.subject.keywordFar vision impairment-
dc.contributor.alternativeNameShin, Jae Il-
dc.contributor.affiliatedAuthorIl Shin, Jae-
dc.identifier.scopusid2-s2.0-85103183873-
dc.identifier.wosid000634301600003-
dc.citation.volume33-
dc.citation.number11-
dc.citation.startPage2995-
dc.citation.endPage3003-
dc.identifier.bibliographicCitationAGING CLINICAL AND EXPERIMENTAL RESEARCH, Vol.33(11) : 2995-3003, 2021-11-
dc.identifier.rimsid70787-
dc.type.rimsART-
dc.description.journalClass1-
dc.description.journalClass1-
dc.subject.keywordAuthorSarcopenia-
dc.subject.keywordAuthorVisual impairment-
dc.subject.keywordAuthorLow-
dc.subject.keywordAuthorand middle-income countries-
dc.subject.keywordAuthorOlder adults-
dc.subject.keywordAuthorFar vision impairment-
dc.subject.keywordPlusWORLD-HEALTH-ORGANIZATION-
dc.subject.keywordPlusOLDER-ADULTS-
dc.subject.keywordPlusVISUAL IMPAIRMENT-
dc.subject.keywordPlusINFLUENTIAL FACTORS-
dc.subject.keywordPlusSEDENTARY BEHAVIOR-
dc.subject.keywordPlusPHYSICAL-ACTIVITY-
dc.subject.keywordPlusMUSCLE MASS-
dc.subject.keywordPlusLIFE-SPAN-
dc.subject.keywordPlusDISABILITY-
dc.subject.keywordPlusPREVALENCE-
dc.type.docTypeArticle-
dc.description.isOpenAccessN-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalWebOfScienceCategoryGeriatrics & Gerontology-
dc.relation.journalResearchAreaGeriatrics & Gerontology-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Pediatrics (소아과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.